ANTISEPTIC SKIN CREAM 2000 UNIT
RETINOL PALMITATE : 2000 UNIT VITAMIN D3 : 500 UNIT BENZETHONIUM CHLORIDE : 1 MG · DIN 01988158 · ARJO CANADA INC
Health Canada status: CANCELLED POST MARKET
What is ANTISEPTIC SKIN CREAM?
ANTISEPTIC SKIN CREAM 2000 UNIT contains RETINOL PALMITATE : 2000 UNIT VITAMIN D3 : 500 UNIT BENZETHONIUM CHLORIDE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 01988158, held by ARJO CANADA INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 12-Nov-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01988158 |
|---|---|
| Brand name | ANTISEPTIC SKIN CREAM |
| Generic / active ingredient | RETINOL PALMITATE : 2000 UNIT VITAMIN D3 : 500 UNIT BENZETHONIUM CHLORIDE : 1 MG |
| Manufacturer | ARJO CANADA INC |
| Strength | 2000 UNIT |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D08AJ58 BENZETHONIUM CHLORIDE, COMBINATIONS |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-Nov-1997 |
| Original market date | 1993-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D08AJ58 BENZETHONIUM CHLORIDE, COMBINATIONS. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BURO SOL ANTISEPTIC POWDER | 0.35 % | POWDER | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 00579947 |
| LIPSOREX | 0.26 % | GEL | CANDERM G.P. | CANCELLED POST MARKET | DIN 02237806 |
| LIPSOREX - GEL | 0.9 % | GEL | VEXCO LABORATORIES INC. | CANCELLED POST MARKET | DIN 02122006 |
| LIPSOREX-GEL | 0.9 % | GEL | VEXCO LABORATORIES INC. | CANCELLED POST MARKET | DIN 02138239 |
| MARCORODEX | 1 G / 100 ML | LIQUID | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 02229710 |
| MRX LIQ | 0.2 % | LIQUID | MAHDEEN MEDICEUTICALS, DIVISION OF ZERON INC. | CANCELLED POST MARKET | DIN 00430765 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.